Peptide reference · Library entry
Retatrutide
LY3437943
Investigational
Status as of
Metabolism
Reading note
Look for the question the investigators intended to answer before examining an interesting finding. A report may also describe observations that prompted a new question during analysis. If that happens, distinguish the original comparison from the later exploration and examine how the authors label each. The distinction does not make an observation uninteresting; it changes what would help test the proposed explanation next. A useful reading note records which result addresses the stated plan and which interpretation would benefit from a separately designed comparison.
Approval scope
Investigational; no FDA-approved product.
Mechanism
Activates GIP, GLP-1 and glucagon receptors.
Evidence
A randomized obesity trial was funded by Lilly.
Limitations
Trial averages do not predict an individual outcome.
Safety context
The trial reported gastrointestinal adverse events.
Formulation and route
Studied as a subcutaneous injection.
Questions to take to the evidence
- Which comparison was specified before the reported observations were examined?
- How does the report distinguish its planned question from later exploration?
- What separate comparison could test the explanation suggested by an exploratory finding?
Sources
- FDA GLP-1
FDA · Checked
- Jastreboff
PubMed · Checked
Connect the next question
Educational reference. AI-assisted editorial content; no independent human medical review. This library does not provide prescribing or self-treatment instructions.